MYC and lung adenocarcinoma: For instance, hepatocarcinoma (HCC) with MYC amplification diminishes glutamine anabolism, while MYC-induced lung adenocarcinoma engages glucose catabolism and increases glutamine levels (Yuneva et al, 2012).